239
Participants
Start Date
February 22, 2016
Primary Completion Date
October 20, 2019
Study Completion Date
June 24, 2021
Nivolumab
Specified dose on specified days
Local Institution, Berlin
USOR - New York Oncology Hematology, P.C., Albany
Maryland Oncology Hematology P.A., Columbia
Virginia Cancer Care Specialist, PC, Fairfax
Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care, Wytheville
Greenville Health System, Greenville
Orlando Health, Inc, Orlando
Memorial Healthcare System, Hollywood
Florida Cancer Specialists, West Palm Beach
Florida Cancer Specialists & Research Institute, St. Petersburg
Florida Cancer Affiliates, Ocala
Tennessee Oncology, Lebanon
West Cancer Center, Germantown
Local Institution, Essen
Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne
Local Institution, Bonn
Minnesota Oncology Hematology, P.A., Minneapolis
Illinois Cancer Specialists, Niles
HCA Midwest Healthcare, Kansas City
Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
Texas Oncology - Baylor Charles A. Simmons Cancer Center, Dallas
Texas Oncology, P.A., Fort Worth
Texas Oncology - Waco, Waco
The University of Texas MD Anderson Cancer Center-merge, Houston
Texas Oncology The Woodlands, The Woodlands
Texas Oncology, P.A., San Antonio
Local Institution, Freiburg im Breisgau
Rocky Mountain Cancer Centers - Denver Midtwon, Denver
St. Mary's Hospital And Regional Medical Center, Grand Junction
Klinikum Rechts der Isar der Technischen Universitaet Muenchen, München
Arizona Oncology Associates, PC, Tucson
Texas Oncology-Austin Central, Las Vegas
LACN, Los Angeles
UCLA Main Campus - University California Los Angeles, Los Angeles
Torrence Health Association, DBA Torrance Memorial;Physician Network/Cancer Care Associates, Redondo Beach
St. Jude Hospital Yorba Linda, Fullerton
Cancer Center of Santa Barbara with Sansum Clinic, Santa Barbara
CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center, Bakersfield
Coastal Integrative Cancer Care, San Luis Obispo
Central Coast Medical Oncology Corporation, Santa Maria
Northwest Cancer Specialists, P.C., Tualatin
Willamette Valley Cancer Institute and Research Center, Springfield
Hematology Oncology Associates, PC, Medford
Saint Barnabas Medical Cancer Center, Livingston
Local Institution, Dresden
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY